Endpoints News 2026年4月6日 Amgen seeks to buoy Tepezza with injectable data in face of incoming competition
Endpoints News 2025年12月12日 FDA broadens label for Amgen's Uplizna as it enters rare disease competition
Endpoints News 2025年12月11日 Weight loss biotech Prolynx gets $70M, snags Amgen's obesity commercial leader as CEO